Category: Disease States

Disease States

Blood Test Shows Promise for Earlier ALS Detection

UCLA Health researchers find cell-free DNA combined with machine learning can distinguish ALS from other neurological conditions.

Disease States

Molecular Designs Seeks FDA Clearance for Respiratory Panel

Multiplex RT-PCR assay detects SARS-CoV-2, influenza A and B, and RSV from nasal swabs with breakaway format for flexible testing.

Disease States

AI-Driven Platform Aims to Bring Personalized Cancer Treatment to More Patients

First Ascent Biomedical is validating a live-cell testing platform that screens over 150 FDA-approved therapies against a patient’s tumor, generating individualized treatment insights in about 10 days.

Cancer

Prospective Trial Shows PAM50 Biomarker Predicts Hormone Therapy Benefit in Prostate Cancer

Study finds molecular signature identifies which men with recurrent disease respond to apalutamide plus salvage radiation therapy.

Infectious Diseases

Mayo Clinic Launches Focused Nine-Gene Panel for Hereditary Pancreatitis

The new test expands from four genes to nine while maintaining clinical focus, addressing diagnostic challenges with PRSS1 testing accuracy.

Womens Health

Fellow Health Joins Progyny Network for Home Male Fertility Testing

Partnership provides mail-in semen analysis as a covered benefit for eligible members.

Allergy & Autoimmune

Why Laboratory Insights Are Critical During Asthma Peak Week

From rising demand for comprehensive IgE profiles to the emergence of molecular allergen diagnostics, laboratories are central to how clinicians prepare for and manage September’s asthma spike.

Cardiovascular, Cerebrovascular

Should Labs Add Lp(a) Testing to Their Menus?

Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.

Dementias & Alzheimer’s

C2N Diagnostics Lowers Age Limit for Alzheimer’s Blood Test to 50

C2N Diagnostics has expanded the intended use of its PrecivityAD2 Alzheimer's disease blood test to include patients 50 years and older, lowering the previous age limit from 60 years.

Diabetes & Metabolic Diseases

Balancing POC and Lab Testing for Diabetes Management

It's essential to integrate point-of-care testing devices cautiously alongside traditional laboratory tests to ensure robust diabetes management.

Kidney Disease

Carna Health, Siemens Healthineers Partner on AI-Enabled CKD Platform

The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

AI-Powered Sepsis Test Shows Promise in Large Clinical Study

TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.